Status:
COMPLETED
A Study of Calcitriol BID Topical Treatment in Adolescents With Plaque Psoriasis
Lead Sponsor:
Galderma R&D
Conditions:
Chronic Plaque Psoriasis
Eligibility:
All Genders
12-17 years
Phase:
PHASE2
Brief Summary
This is an open-label, multicenter study to assess the systemic exposure to calcitriol in the adolescent population. Calcitriol 3µg/g ointment (2 mg/cm² per application) is to be applied twice daily t...
Eligibility Criteria
Inclusion
- Diagnosis of chronic plaque psoriasis
- 10 - 35% BSA of involved skin
- Age 12 - 17
Exclusion
- Other type of psoriasis (other than plaque)
- Significant abnormal lab findings
- Vit D insufficiency
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 24 2009
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00419666
Start Date
August 1 2006
End Date
September 24 2009
Last Update
February 18 2021
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Dermatology Research of Arkansas
Little Rock, Arkansas, United States, 72205
2
Children's Hospital, Department of Pediatric and Adolescent Dermatology
San Diego, California, United States, 92123
3
Dermatology Center For Children & Young Adults
Eagan, Minnesota, United States, 55121
4
University of Texas-Houston Medical Center Dept of Dermatology
Houston, Texas, United States, 77030